TWI840448B - 二唑酮化合物及醫藥 - Google Patents
二唑酮化合物及醫藥 Download PDFInfo
- Publication number
- TWI840448B TWI840448B TW108141565A TW108141565A TWI840448B TW I840448 B TWI840448 B TW I840448B TW 108141565 A TW108141565 A TW 108141565A TW 108141565 A TW108141565 A TW 108141565A TW I840448 B TWI840448 B TW I840448B
- Authority
- TW
- Taiwan
- Prior art keywords
- amino
- oxadiazole
- phenyl
- ethyl
- trifluoromethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018214950 | 2018-11-15 | ||
| JP2018-214950 | 2018-11-15 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202031649A TW202031649A (zh) | 2020-09-01 |
| TWI840448B true TWI840448B (zh) | 2024-05-01 |
Family
ID=70731909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW108141565A TWI840448B (zh) | 2018-11-15 | 2019-11-15 | 二唑酮化合物及醫藥 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20220024921A1 (https=) |
| EP (1) | EP3882239A4 (https=) |
| JP (1) | JP7434172B2 (https=) |
| KR (1) | KR20210091767A (https=) |
| CN (1) | CN113302184B (https=) |
| AU (1) | AU2019381493B2 (https=) |
| BR (1) | BR112021009198A2 (https=) |
| CA (1) | CA3117550A1 (https=) |
| CL (1) | CL2021001275A1 (https=) |
| CO (1) | CO2021007442A2 (https=) |
| EA (1) | EA202191349A1 (https=) |
| EC (1) | ECSP21034281A (https=) |
| IL (1) | IL282999A (https=) |
| MA (1) | MA54243A (https=) |
| MX (1) | MX2021005566A (https=) |
| PE (1) | PE20211283A1 (https=) |
| PH (1) | PH12021551103A1 (https=) |
| SA (1) | SA521421997B1 (https=) |
| SG (1) | SG11202104371XA (https=) |
| TW (1) | TWI840448B (https=) |
| UA (1) | UA129949C2 (https=) |
| WO (1) | WO2020100959A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4516778A4 (en) | 2022-04-25 | 2026-04-29 | Nippon Shinyaku Co Ltd | COMPOUND SERVING AS A DDR1 KINASE INHIBITOR AND MEDICINE |
| CN117285459B (zh) * | 2023-11-24 | 2024-02-27 | 上海美迪西生物医药股份有限公司 | 一种小分子激酶抑制剂化合物的制备方法 |
| CN118515653B (zh) * | 2024-07-23 | 2024-12-10 | 西湖制药(杭州)有限公司 | 一种ezh2特异性抑制剂及其制备方法和用途 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026149A1 (en) * | 2003-09-13 | 2005-03-24 | Astrazeneca Ab | Pyrrol derivatives with antibacterial activity |
| JP2011515337A (ja) * | 2008-02-29 | 2011-05-19 | サイレーン ファーマシューティカルズ， インコーポレイテッド | プロテインキナーゼモジュレーター |
| JP2014500277A (ja) * | 2010-12-09 | 2014-01-09 | アムジエン・インコーポレーテツド | Ｐｉｍ阻害剤としての二環式化合物 |
| JP2014510105A (ja) * | 2011-03-22 | 2014-04-24 | アムジエン・インコーポレーテツド | Ｐｉｍ阻害剤としてのアゾール化合物 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01139581A (ja) * | 1987-08-20 | 1989-06-01 | Nissan Chem Ind Ltd | テトラヒドロフタルイミド誘導体、その製法および除草剤 |
| EP1797040A1 (en) | 2004-09-29 | 2007-06-20 | Ranbaxy Laboratories Limited | Muscarinic receptor antagonists |
| CA2591738A1 (en) | 2004-12-22 | 2006-06-29 | Merck & Co., Inc. | Process for making substituted piperidines |
| GB0813740D0 (en) | 2008-07-28 | 2008-09-03 | Angeletti P Ist Richerche Biologica | Therapeutic compounds |
| TWI496779B (zh) | 2008-08-19 | 2015-08-21 | Array Biopharma Inc | 作為ｐｉｍ激酶抑制劑之三唑吡啶化合物 |
| WO2013007765A1 (en) | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| CN104540830A (zh) | 2012-06-07 | 2015-04-22 | 霍夫曼-拉罗奇有限公司 | 端锚聚合酶的吡唑并嘧啶酮和吡唑并吡啶酮抑制剂 |
| GB201814151D0 (en) | 2018-08-31 | 2018-10-17 | Ucl Business Plc | Compounds |
-
2019
- 2019-11-14 EA EA202191349A patent/EA202191349A1/ru unknown
- 2019-11-14 WO PCT/JP2019/044615 patent/WO2020100959A1/ja not_active Ceased
- 2019-11-14 CN CN201980089037.7A patent/CN113302184B/zh active Active
- 2019-11-14 BR BR112021009198-0A patent/BR112021009198A2/pt unknown
- 2019-11-14 AU AU2019381493A patent/AU2019381493B2/en active Active
- 2019-11-14 KR KR1020217017903A patent/KR20210091767A/ko active Pending
- 2019-11-14 MX MX2021005566A patent/MX2021005566A/es unknown
- 2019-11-14 PE PE2021000693A patent/PE20211283A1/es unknown
- 2019-11-14 MA MA054243A patent/MA54243A/fr unknown
- 2019-11-14 US US17/293,929 patent/US20220024921A1/en active Pending
- 2019-11-14 CA CA3117550A patent/CA3117550A1/en active Pending
- 2019-11-14 SG SG11202104371XA patent/SG11202104371XA/en unknown
- 2019-11-14 EP EP19883405.3A patent/EP3882239A4/en not_active Withdrawn
- 2019-11-14 JP JP2020556150A patent/JP7434172B2/ja active Active
- 2019-11-14 UA UAA202103273A patent/UA129949C2/uk unknown
- 2019-11-15 TW TW108141565A patent/TWI840448B/zh active
-
2021
- 2021-05-06 IL IL282999A patent/IL282999A/en unknown
- 2021-05-10 SA SA521421997A patent/SA521421997B1/ar unknown
- 2021-05-14 CL CL2021001275A patent/CL2021001275A1/es unknown
- 2021-05-14 PH PH12021551103A patent/PH12021551103A1/en unknown
- 2021-05-14 EC ECSENADI202134281A patent/ECSP21034281A/es unknown
- 2021-06-08 CO CONC2021/0007442A patent/CO2021007442A2/es unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005026149A1 (en) * | 2003-09-13 | 2005-03-24 | Astrazeneca Ab | Pyrrol derivatives with antibacterial activity |
| JP2011515337A (ja) * | 2008-02-29 | 2011-05-19 | サイレーン ファーマシューティカルズ， インコーポレイテッド | プロテインキナーゼモジュレーター |
| JP2014500277A (ja) * | 2010-12-09 | 2014-01-09 | アムジエン・インコーポレーテツド | Ｐｉｍ阻害剤としての二環式化合物 |
| JP2014510105A (ja) * | 2011-03-22 | 2014-04-24 | アムジエン・インコーポレーテツド | Ｐｉｍ阻害剤としてのアゾール化合物 |
Non-Patent Citations (1)
| Title |
|---|
| 期刊 Ah Yeon Lee, et al. "1,3,4-Oxadiazole-2(3H)-thione as a New Scaffold for Pim Kinase Inhibitors." Quantitative Bio-Science, Vol.37 No.2, 2018.11 ;113-124. * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019381493B2 (en) | 2024-10-31 |
| SA521421997B1 (ar) | 2025-04-10 |
| JP7434172B2 (ja) | 2024-02-20 |
| PH12021551103A1 (en) | 2021-11-22 |
| CL2021001275A1 (es) | 2021-11-05 |
| JPWO2020100959A1 (ja) | 2021-10-07 |
| ECSP21034281A (es) | 2021-06-30 |
| PE20211283A1 (es) | 2021-07-19 |
| EP3882239A1 (en) | 2021-09-22 |
| US20220024921A1 (en) | 2022-01-27 |
| MA54243A (fr) | 2021-09-22 |
| AU2019381493A1 (en) | 2021-06-03 |
| CN113302184B (zh) | 2024-11-22 |
| UA129949C2 (uk) | 2025-09-24 |
| TW202031649A (zh) | 2020-09-01 |
| KR20210091767A (ko) | 2021-07-22 |
| WO2020100959A1 (ja) | 2020-05-22 |
| EP3882239A4 (en) | 2022-08-10 |
| IL282999A (en) | 2021-06-30 |
| CN113302184A (zh) | 2021-08-24 |
| SG11202104371XA (en) | 2021-05-28 |
| EA202191349A1 (ru) | 2021-08-10 |
| CA3117550A1 (en) | 2020-05-22 |
| CO2021007442A2 (es) | 2021-06-21 |
| MX2021005566A (es) | 2021-07-15 |
| BR112021009198A2 (pt) | 2021-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12110292B2 (en) | Ligands to cereblon (CRBN) | |
| CN113501821B (zh) | 具有mgat-2抑制活性的稠合环衍生物 | |
| CN102666489B (zh) | 鞘氨醇激酶抑制剂 | |
| CN114828959A (zh) | 3-(5-甲氧基-1-氧代异吲哚啉-2-基)哌啶-2,6-二酮衍生物及其用途 | |
| CN108697715A (zh) | 包含帽依赖性核酸内切酶抑制剂及抗流感药的组合的流感治疗用药物 | |
| UA121658C2 (uk) | Сполуки 5-хлордифторметоксифенілпіразолопіримідину як інгібітори янус-кінази | |
| WO2014007228A1 (ja) | ソマトスタチン受容体作動活性を有する化合物およびその医薬用途 | |
| CN107074805B (zh) | 用于治疗疾病的gls1抑制剂 | |
| TW201341385A (zh) | 咪唑［１，２－ｂ］噠嗪基化合物、包含其之組成物及其使用方法 | |
| TWI840448B (zh) | 二唑酮化合物及醫藥 | |
| BR112016017317B1 (pt) | Composto, e, uso de um composto | |
| TW201211053A (en) | Spiro compound and drug for activating adiponectin receptor | |
| JP7592748B2 (ja) | 抗ウイルス１，３－ジ－オキソ－インデン化合物 | |
| TWI868068B (zh) | 氮雜苯並咪唑化合物及醫藥 | |
| CN108137609A (zh) | 用作TNFα的调节剂的环状化合物 | |
| US10584116B2 (en) | Heterocyclic sulfonamide derivative and medicine containing same | |
| TW202333663A (zh) | Rxfp1促效劑 | |
| KR20230035311A (ko) | Nek7 키나제의 억제제 | |
| JP7187490B2 (ja) | 寄生虫症の治療のための５，６－縮合二環式化合物及び組成物 | |
| JP2019519576A (ja) | ミエロペルオキシダーゼのマクロ環阻害剤 | |
| HK40051487B (zh) | 1,3,4-恶二唑啉酮化合物和药物 | |
| CN118103352A (zh) | Kif18a的螺吲哚啉抑制剂 | |
| HK40051487A (en) | 1,3,4-oxadiazolone compound and medicine | |
| HK40051017A (en) | 1,3,4-oxadiazolone compound and medicine | |
| HK40113963A (zh) | Pd-1/pd-l1抑制剂 |